Mayuko Moriyama
Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Changes in serious infection and mortality among patients with ANCA-associated vasculitis during the COVID-19 pandemic: an interrupted time-series analysis of J-CANVAS.
Journal: EULAR rheumatology open
Published: August 01, 2026
Effectiveness and safety of rituximab for remission maintenance therapy in microscopic polyangiitis and granulomatosis with polyangiitis in Japan: A retrospective multicentre cohort study (J-CANVAS).
Journal: Modern rheumatology
Published: December 08, 2025
Predictors of glucocorticoid-free clinical remission in patients with newly diagnosed microscopic polyangiitis and granulomatosis with polyangiitis: a retrospective cohort study using a nationwide registry in Japan (J-CANVAS).
Journal: Arthritis research & therapy
Published: November 29, 2025
Triple therapy with caplacizumab and rituximab for refractory systemic lupus erythematosus-associated thrombotic thrombocytopenic purpura achieves rapid, durable remission: A case report.
Journal: Modern rheumatology case reports
Published: November 26, 2025
Refractory Systemic Lupus Erythematosus-associated Pericarditis Treated with Anifrolumab.
Journal: Internal medicine (Tokyo, Japan)
Published: October 15, 2025
Association Between Bronchiectasis and Serious Infections in Microscopic Polyangiitis and Granulomatosis With Polyangiitis From the J-CANVAS.
Journal: International journal of rheumatic diseases
Published: September 24, 2025
Modification of 2022 ACR/EULAR ANCA-associated vasculitis classification criteria in a Japanese cohort (J-CANVAS).
Journal: Clinical and experimental rheumatology
Published: July 07, 2025
Phenotype, serotype, and data-driven clustering reveal complementary dimensions of heterogeneity in ANCA-associated vasculitis: a multicentre Japanese cohort (J-CANVAS).
Journal: Rheumatology international
Published: June 25, 2025
Diabetes mellitus and cardiac disease as key predictors of rituximab-induced acute thrombocytopenia in ANCA-associated vasculitis.
Journal: Rheumatology (Oxford, England)
Published: June 12, 2025
Effectiveness for remission maintenance rate and safety of different rituximab regimens for treating anti-neutrophil cytoplasmic antibody-associated vasculitis in Japan: a J-CANVAS study.
Journal: Immunological medicine
Published: January 11, 2025
Tocilizumab Increases Serum Lipids but Does Not Increase Arteriosclerosis, As Measured by Intima-Media Thickness, in Patients With Rheumatoid Arthritis.
Journal: Cureus
Published: January 01, 2025
Last Updated: 09/26/2026